Rhythm Pharmaceuticals RYTM Stock
Rhythm Pharmaceuticals Price Chart
Rhythm Pharmaceuticals RYTM Financial and Trading Overview
| Rhythm Pharmaceuticals stock price | 61.34 USD |
| Previous Close | 49.05 USD |
| Open | 49.06 USD |
| Bid | 48.62 USD x 200 |
| Ask | 48.81 USD x 200 |
| Day's Range | 47.49 - 49.79 USD |
| 52 Week Range | 18.99 - 53.92 USD |
| Volume | 412.08K USD |
| Avg. Volume | 560.06K USD |
| Market Cap | 2.97B USD |
| Beta (5Y Monthly) | 2.043 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.33 USD |
RYTM Valuation Measures
| Enterprise Value | 2.88B USD |
| Trailing P/E | N/A |
| Forward P/E | -19.418327 |
| PEG Ratio (5 yr expected) | 1.23 |
| Price/Sales (ttm) | 32.32839 |
| Price/Book (mrq) | 48.257427 |
| Enterprise Value/Revenue | 31.319 |
| Enterprise Value/EBITDA | -10.663 |
Trading Information
Rhythm Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 2.043 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 53.92 USD |
| 52 Week Low | 18.99 USD |
| 50-Day Moving Average | 42.78 USD |
| 200-Day Moving Average | 39.82 USD |
RYTM Share Statistics
| Avg. Volume (3 month) | 560.06K USD |
| Avg. Daily Volume (10-Days) | 492.64K USD |
| Shares Outstanding | 60.97M |
| Float | 45.6M |
| Short Ratio | 17.54 |
| % Held by Insiders | 0.54% |
| % Held by Institutions | 116.52% |
| Shares Short | 10.07M |
| Short % of Float | 25.28% |
| Short % of Shares Outstanding | 16.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | -297.92% |
| Operating Margin (ttm) | -538.71% |
| Gross Margin | 88.37% |
| EBITDA Margin | -293.72% |
Management Effectiveness
| Return on Assets (ttm) | -56.20% |
| Return on Equity (ttm) | -194.68% |
Income Statement
| Revenue (ttm) | 91.93M USD |
| Revenue Per Share (ttm) | 1.57 USD |
| Quarterly Revenue Growth (yoy) | 126.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -270007008 USD |
| Net Income Avi to Common (ttm) | -273871008 USD |
| Diluted EPS (ttm) | -4.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 201.2M USD |
| Total Cash Per Share (mrq) | 3.3 USD |
| Total Debt (mrq) | 108.45M USD |
| Total Debt/Equity (mrq) | 176.1 USD |
| Current Ratio (mrq) | 4.353 |
| Book Value Per Share (mrq) | 1.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -140467008 USD |
| Levered Free Cash Flow (ttm) | -188313872 USD |
Profile of Rhythm Pharmaceuticals
| Country | United States |
| State | MA |
| City | Boston |
| Address | 222 Berkeley Street |
| ZIP | 02116 |
| Phone | 857 264 4280 |
| Website | https://rhythmtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 226 |
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Q&A For Rhythm Pharmaceuticals Stock
What is a current RYTM stock price?
Rhythm Pharmaceuticals RYTM stock price today per share is 61.34 USD.
How to purchase Rhythm Pharmaceuticals stock?
You can buy RYTM shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rhythm Pharmaceuticals?
The stock symbol or ticker of Rhythm Pharmaceuticals is RYTM.
Which industry does the Rhythm Pharmaceuticals company belong to?
The Rhythm Pharmaceuticals industry is Biotechnology.
How many shares does Rhythm Pharmaceuticals have in circulation?
The max supply of Rhythm Pharmaceuticals shares is 63.22M.
What is Rhythm Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Rhythm Pharmaceuticals PE Ratio is now.
What was Rhythm Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Rhythm Pharmaceuticals EPS is -4.34 USD over the trailing 12 months.
Which sector does the Rhythm Pharmaceuticals company belong to?
The Rhythm Pharmaceuticals sector is Healthcare.
Rhythm Pharmaceuticals RYTM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| NASDAQ Global Market Composite NQGM | 1727.53 USD — |
-1.77
|
— — | 1703.28 USD — | 1740.16 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1966.83 USD — |
-0.91
|
— — | 1943.77 USD — | 1985.27 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2635.39 USD — |
-1.24
|
— — | 2606.48 USD — | 2665.89 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3931.86 USD — |
-1.96
|
— — | 3898 USD — | 4000.18 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
- {{ link.label }} {{link}}